Merck & Co., Inc. CEDEAR (MRK)
BCBA
Closed
Aug 21, 2026
Day's Range
47,380.0052 wk Range
21,600.00Overview - MRK - Merck & Co., Inc. CEDEAR
Key Statistics
Valuation
Enterprise Value
1,434,586.16T
P/E (Trailing)
‪2.59‬
PEG Ratio
‪-0.01‬
Price / Sales (TTM)
‪179.97‬
Price / Book
‪15.50‬
EV / EBITDA
‪33,199.18‬
Profitability
Gross Margin
‪73.53%‬
Profit Margin
‪4.76%‬
Operating Margin
‪-0.24%‬
Return on Assets
‪11.86%‬
Return on Equity
‪6.96%‬
Ownership
Shares Outstanding
2.46B
Float
19.70B
Held by Insiders
‪0.00%‬
Held by Institutions
‪0.00%‬
Price stats
Beta
‪0.21‬
50-Day Avg
‪39,852.40‬
200-Day Avg
‪35,134.20‬
Dividends
Payout Ratio
‪5.38%‬
Frequency
Quarterly
Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - MRK - Merck & Co., Inc. CEDEAR
Peers - MRK - Merck & Co., Inc. CEDEAR
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on BCBA.
Profile Summary - MRK - Merck & Co., Inc. CEDEAR
About
Merck & Co., Inc. CEDEAR is an Argentine depositary receipt that represents an economic interest in shares of Merck & Co., Inc., a global biopharmaceutical company focused on prescription medicines, vaccines, and animal health products. Its primary purpose is to provide local investors peso-denominated access to…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
